Dr. Nathan Bennett, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9755 W State Highway 22, Ratcliff, AR 72951 Phone: 479-635-5300 Fax: 479-635-4700 |
News Archive
Studies conducted at the Comprehensive Cancer Center at MedUni Vienna and Vienna General Hospital show that the drugs ibrutinib and idelalisib used in the targeted treatment of chronic lymphatic leukaemia can significantly prolong the survival time of high-risk patients.
Is it possible that liposuction or other fat removal procedures are beneficial for treating obesity and reducing the risk of cancer? When it comes to humans, scientists can't answer that question. They know that obesity increases the risk of heart disease, diabetes and cancer. But there have not been clinical studies to determine if the surgical removal of fat tissue would decrease cancer risk in humans.
Meritage Pharma, Inc. announced that it has initiated a Phase 2 clinical trial to evaluate oral budesonide suspension (OBS) for the treatment of adolescents and young adults with eosinophilic esophagitis (EoE), an allergic inflammatory condition of the esophagus. EoE is a chronic disease characterized by symptoms related to esophageal dysfunction and eosinophil-predominant inflammation.
Sheffield Hallam University's award winning outreach team is featured in a new national guide for supporting care leavers wanting to come to university.
› Verified 2 days ago